Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire

Journal of Neuro-Oncology

Volumn 116, Issue 2, 2014, Pages 283-290

  Sizoo, Eefje M ^a   Dirven, Linda ^a   Reijneveld, Jaap C ^a,b   Postma, Tjeerd J ^a   Heimans, Jan J ^a   Deliens, Luc ^a,c   Pasman, H Roeline W ^a   Taphoorn, Martin J B ^a,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

End of life; Glioma; Health related quality of life; Psychometric properties

Indexed keywords

ADULT; AGED; ARTICLE; COGNITION; CONTENT VALIDITY; DEATH; DYING; FAMILY LIFE; FEMALE; GLIOMA; HUMAN; HUMAN DIGNITY; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PSYCHOLOGICAL WELL BEING; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIGION; SOCIAL ASPECT; SOCIAL SUPPORT; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COGNITION DISORDERS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PROXY; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TERMINAL CARE;

EID: 84893690391     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1289-x     Document Type: Article

References (42)

1. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY (2003) Primary brain tumours in adults. Lancet 361:323-331
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
3. World Health Organization (2002) Definition of palliative care. WHO, Geneva. http://www.who.int/cancer/palliative/definition/en. Accessed 11 March 2013
4. Ostgathe C, Gaertner J, Kotterba M, Klein S, Lindena G, Nauck F, Radbruch L, Voltz R (2010) Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer 18:1157-1163
5. Bausewein C, Hau P, Borasio GD, Voltz R (2003) How do patients with primary brain tumours die? Palliat Med 17:558-559
6. Oberndorfer S, Lindeck-Pozza E, Lahrmann H, Struhal W, Hitzenberger P, Grisold W (2008) The end-of-life hospital setting in patients with glioblastoma. J Palliat Med 11:26-30
7. Pace A, Di Lorenzo C, Guariglia L, Jandolo B, Carapella CM, Pompili A (2009) End of life issues in brain tumor patients. J Neurooncol 91:39-43
8. Pace A, Villani V, Di Lorenzo C, Guariglia L, Maschio M, Pompili A, Carapella CM (2013) Epilepsy in the end-of-life phase in patients with high-grade gliomas. J Neurooncol 111:83-86
9. Sizoo EM, Braam L, Postma TJ, Pasman HR, Heimans JJ, Klein M, Reijneveld JC, Taphoorn MJ (2010) Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro Oncol 12:1162-1166
10. Cavers D, Hacking B, Erridge SC, Morris PG, Kendall M, Murray SA (2012) Adjustment and support needs of glioma patients and their relatives: serial interviews. Psychooncology 22(6):1299-1305
11. Davies E, Clarke C (2005) Views of bereaved relatives about quality of survival after radiotherapy for malignant cerebral glioma. J Neurol Neurosurg Psychiatry 76:555-561
12. Aaronson NK (1988) Quality of life: what is it? How should it be measured? Oncology (Williston Park) 2(69-76):64
13. Albers G, Echteld MA, de Vet HC, Onwuteaka-Philipsen BD, van der Linden MH, Deliens L (2010) Content and spiritual items of quality-of-life instruments appropriate for use in palliative care: a review. J Pain Symptom Manag 40:290-300
14. Steinhauser KE, Clipp EC, Tulsky JA (2002) Evolution in measuring the quality of dying. J Palliat Med 5:407-414
15. Stewart AL, Teno J, Patrick DL, Lynn J (1999) The concept of quality of life of dying persons in the context of health care. J Pain Symptom Manag 17:93-108
16. Taphoorn MJ, Sizoo EM, Bottomley A (2010) Review on quality of life issues in patients with primary brain tumors. Oncologist 15:618-626
17. Byock IR, Merriman MP (1998) Measuring quality of life for patients with terminal illness: the Missoula-VITAS quality of life index. Palliat Med 12:231-244
18. Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, Tong K (1997) Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med 11:3-20
19. Steinhauser KE, Bosworth HB, Clipp EC, McNeilly M, Christakis NA, Parker J, Tulsky JA (2002) Initial assessment of a new instrument to measure quality of life at the end of life. J Palliat Med 5:829-841
20. Sterkenburg CA, King B, Woodward CA (1996) A reliability and validity study of the McMaster Quality of Life Scale (MQLS) for a palliative population. J Palliat Care 12:18-25
21. Earle CC, Ayanian JZ (2006) Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol 24:838-840
22. Patrick DL, Erickson P (1993) Health status and health policy: quality of life in health care evaluation and resource allocation. Oxford University Press, New York
23. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
24. Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42:55-64
25. Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, Brada M, Newlands E (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139-150
26. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483
27. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA (1995) The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75:1151-1161
28. Faithfull S, Cook K, Lucas C (2005) Palliative care of patients with a primary malignant brain tumour: case review of service use and support provided. Palliat Med 19:545-550
29. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HC (2010) The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 63:737-745
30. Sizoo EM, Pasman HR, Buttolo J, Heimans JJ, Klein M, Deliens L, Reijneveld JC, Taphoorn MJ (2012) Decision-making in the end-of-life phase of high-grade glioma patients. Eur J Cancer 48:226-232
31. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organization for Research and Treatment of Cancer, Brussels
32. Fayers P, Machin D (2000) Quality of life: assessment, analysis and Interpretation. Wiley, Chichester
33. Brown PD, Decker PA, Rummans TA, Clark MM, Frost MH, Ballman KV, Arusell RM, Buckner JC (2008) A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life. Am J Clin Oncol 31:163-168
34. Sneeuw KC, Aaronson NK, Osoba D, Muller MJ, Hsu MA, Yung WK, Brada M, Newlands ES (1997) The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care 35:490-506
35. Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH (1998) Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51:617-631
36. Stephens RJ, Hopwood P, Girling DJ, Machin D (1997) Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Qual Life Res 6:225-236
37. Giesinger JM, Golser M, Erharter A, Kemmler G, Schauer-Maurer G, Stockhammer G, Muigg A, Hutterer M, Rumpold G, Holzner B (2009) Do neurooncological patients and their significant others agree on quality of life ratings? Health Qual Life Outcomes 7:87
38. Milne DJ, Mulder LL, Beelen HC, Schofield P, Kempen GI, Aranda S (2006) Patients' self-report and family caregivers' perception of quality of life in patients with advanced cancer: how do they compare? Eur J Cancer Care (Engl) 15:125-132
39. Sprangers MA, Aaronson NK (1992) The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol 45:743-760
40. Sneeuw KC, Sprangers MA, Aaronson NK (2002) The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol 55:1130-1143
41. Ford E, Catt S, Chalmers A, Fallowfield L (2012) Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol 14:392-404
42. Sizoo EM, Taphoorn MJ, Uitdehaag B, Heimans JJ, Deliens L, Reijneveld JC, Pasman HR (2013) The end-of-life phase of high-grade glioma patients: dying with dignity? Oncologist 18:198-203